MedTrace Logo

Pregnancy Outcomes With a GnRH Antagonist Protocol Versus GnRH-Agonist Protocol in ICSI Cycles

NCT00485537 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2005

Last updated 2007-06-13

No results posted yet for this study

Summary

Cycles with GnRH agonist and GnRH antagonist were compared and main outcome measures were the number of oocytes retrieved, injected and fertilized, embryos transferred, and clinical pregnancy and miscarriage rates, were analized.

Conditions

Interventions

PROCEDURE

oocyte retrieval and ICSI procedure

Sponsors & Collaborators

  • Clinic and Research Center in Human Reproduction Roger Abdelmassih

    lead OTHER

Principal Investigators

  • Rosa M Neme, MD,PhD · Clinic and Research Center in Human Reproduction Roger Abdelmassih

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
22 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Completion
2006-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00485537 on ClinicalTrials.gov